{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:32:03Z","timestamp":1784367123097,"version":"3.55.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T00:00:00Z","timestamp":1531267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P20 CA210300-01"],"award-info":[{"award-number":["P20 CA210300-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0199745","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T13:45:03Z","timestamp":1531316703000},"page":"e0199745","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Disparities by race, age, and sex in the improvement of survival for lymphoma: Findings from a population-based study"],"prefix":"10.1371","volume":"13","author":[{"given":"Fahad","family":"Mukhtar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Boffetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashir","family":"Dabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Y.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi T. D.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuan V.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huong Thi-Thanh","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"Whitney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey A.","family":"Risch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linh C.","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ou","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2172-1849","authenticated-orcid":true,"given":"Hung N.","family":"Luu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,7,11]]},"reference":[{"key":"ref1","first-page":"320","article-title":"Effectiveness of pegaspargase, gemcitabine, and oxaliplatin (P-GEMOX) chemotherapy combined with radiotherapy in newly diagnosed, stage IE to IIE, nasal-type, extranodal natural killer\/T-cell lymphoma","volume":"22","author":"W Wei","year":"2017","journal-title":"Hematol Amst Neth"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1289\/ehp.1409294","article-title":"Occupation and Risk of Non-Hodgkin Lymphoma and Its Subtypes: A Pooled Analysis from the InterLymph Consortium","volume":"124","author":"A \u2018t Mannetje","year":"2016","journal-title":"Environ Health Perspect"},{"key":"ref3","unstructured":"National Cancer Institute. Overview of the SEER Program [Internet]. National Cancer Institute; 2018. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/seer.cancer.gov\/about\/\" xlink:type=\"simple\">http:\/\/seer.cancer.gov\/about\/<\/ext-link>"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1200\/JCO.2013.54.8644","article-title":"Cancer treatment disparities in HIV-infected individuals in the United States","volume":"32","author":"G Suneja","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1080\/09540121.2015.1011074","article-title":"Trends in cancer diagnoses and survival among persons with AIDS in a high HIV prevalence urban area","volume":"27","author":"AD Castel","year":"2015","journal-title":"AIDS Care"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin\u2019s lymphoma","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1200\/JCO.2005.04.503","article-title":"Improved survival of follicular lymphoma patients in the United States","volume":"23","author":"WT Swenson","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1080\/10428190601187703","article-title":"The impact of gender, age and patient selection on prognosis and outcome in diffuse large B-cell lymphoma\u2014a population-based study","volume":"48","author":"S Hasselblom","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1200\/JCO.2008.18.8052","article-title":"Improvements in survival after follicular lymphoma by race\/ethnicity and socioeconomic status: a population-based study","volume":"27","author":"THM Keegan","year":"2009","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1600-0609.2010.01541.x","article-title":"Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapy","volume":"86","author":"S Riihij\u00e4rvi","year":"2011","journal-title":"Eur J Haematol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1182\/blood-2013-07-517110","article-title":"Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era","volume":"123","author":"L Tao","year":"2014","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/jnci\/94.5.334","article-title":"Racial and ethnic disparities in the receipt of cancer treatment","volume":"94","author":"VL Shavers","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/cncr.23228","article-title":"Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002?","volume":"112","author":"CP Gross","year":"2008","journal-title":"Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/jnci\/dji289","article-title":"Annual report to the nation on the status of cancer, 1975\u20132002, featuring population-based trends in cancer treatment","volume":"97","author":"BK Edwards","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1200\/JCO.2003.08.010","article-title":"Participation of patients 65 years of age or older in cancer clinical trials","volume":"21","author":"JH Lewis","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2307\/1912557","article-title":"Likelihood Ratio Tests for Model Selection and Non-nested Hypotheses","volume":"57","author":"QH Vuong","year":"1989","journal-title":"Econometrica"},{"key":"ref17","first-page":"19","article-title":"Robust properties of likelihood ratio tests","volume":"69","author":"JT Kent","year":"1982","journal-title":"Biometrika"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1389201003379059","article-title":"Rituximab: the first monoclonal antibody approved for the treatment of lymphoma","volume":"1","author":"AJ Grillo-L\u00f3pez","year":"2000","journal-title":"Curr Pharm Biotechnol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2009.10.002","article-title":"The development of antiretroviral therapy and its impact on the HIV-1\/AIDS pandemic","volume":"85","author":"S Broder","year":"2010","journal-title":"Antiviral Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.beha.2012.01.001","article-title":"HIV-associated lymphoma","volume":"25","author":"LD Kaplan","year":"2012","journal-title":"Best Pract Res Clin Haematol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/jamaoncol.2014.161","article-title":"Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010","volume":"1","author":"C Zeng","year":"2015","journal-title":"JAMA Oncol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM199807023390104","article-title":"Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin\u2019s lymphoma","volume":"339","author":"TP Miller","year":"1998","journal-title":"N Engl J Med"},{"key":"ref23","unstructured":"Glick J, Kim K, Earle J, O\u2019connell M. An ECOG randomised Phase III trial of CHOP vsCHOP+radiotherapy for intermediate grade early stage non-Hodgkin\u2019s lymphoma. Proceedings of the Annual Meeting of the American Society of Clinical Oncology; 1995."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1200\/JCO.2014.55.1168","article-title":"Radiation treatment in older patients: a framework for clinical decision making","volume":"32","author":"GL Smith","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1040-8428(00)00109-8","article-title":"Cancer and age in the USA","volume":"37","author":"L Balducci","year":"2001","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/cncr.22939","article-title":"Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy","volume":"110","author":"M Shayne","year":"2007","journal-title":"Cancer"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1200\/JCO.2010.31.3049","article-title":"Impact of comorbidity on chemotherapy use and outcomes in solid tumors: a systematic review","volume":"29","author":"L Lee","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1200\/JCO.2010.31.0664","article-title":"Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study","volume":"29","author":"P Caillet","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/ijc.30576","article-title":"Survival predictors of Burkitt\u2019s lymphoma in children, adults and elderly in the United States during 2000\u20132013","volume":"140","author":"F Mukhtar","year":"2017","journal-title":"Int J Cancer"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1634\/theoncologist.2009-0198","article-title":"How does older age influence oncologists\u2019 cancer management?","volume":"15","author":"JA Foster","year":"2010","journal-title":"The Oncologist"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.291.22.2720","article-title":"Participation in cancer clinical trials: race-, sex-, and age-based disparities","volume":"291","author":"VH Murthy","year":"2004","journal-title":"JAMA"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1200\/JCO.2004.02.175","article-title":"Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration","volume":"22","author":"L Talarico","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1200\/JCO.2006.10.1022","article-title":"Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer","volume":"26","author":"C Owusu","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1200\/JCO.1988.6.12.1838","article-title":"The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin\u2019s lymphoma","volume":"6","author":"JM Vose","year":"1988","journal-title":"J Clin Oncol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1089\/jayao.2014.0037","article-title":"Survival Differences by Race\/Ethnicity and Neighborhood Socioeconomic Status in Adolescents and Young Adults Diagnosed with Non-Hodgkin Lymphoma","volume":"4","author":"C Chao","year":"2015","journal-title":"J Adolesc Young Adult Oncol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s10552-015-0609-1","article-title":"US trends in survival disparities among adolescents and young adults with non-Hodgkin lymphoma","volume":"26","author":"EE Kent","year":"2015","journal-title":"Cancer Causes Control"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/ajh.23708","article-title":"The impact of race, age, and sex in follicular lymphoma: A comprehensive SEER analysis across consecutive treatment eras","volume":"89","author":"C Nabhan","year":"2014","journal-title":"Am J Hematol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1093\/annonc\/mdr578","article-title":"Racial disparities in Hodgkin\u2019s lymphoma: a comprehensive population-based analysis","volume":"23","author":"AM Evens","year":"2012","journal-title":"Ann Oncol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.juro.2012.11.153","article-title":"Sex disparities in cancer mortality: the risks of being a man in the United States","volume":"189","author":"BB Najari","year":"2013","journal-title":"J Urol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10552-008-9147-4","article-title":"Lymphoma survival patterns by WHO subtype in the United States, 1973\u20132003","volume":"19","author":"X Han","year":"2008","journal-title":"Cancer Causes Control"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0199745","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T12:48:59Z","timestamp":1571575739000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0199745"}},"subtitle":[],"editor":[{"given":"Arianna","family":"Di Napoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,7,11]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,7,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0199745","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,11]]}}}